Surmodics | SRDX - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Abbott USD 4.92B 535M 2025-12
Align Technology USD 363.97M 7.48M 2025-12
Anika Therapeutics USD 11.44M 797K 2025-12
Artivion USD 42.85M 3.86M 2025-12
Baxter International USD 2.4B 512M 2025-12
Boston Scientific USD 1.84B 82M 2025-12
EDAP TMS EUR 7.91M 1.31M 2025-09
Edwards Lifesciences USD 343M 2.2M 2025-12
Haemonetics USD 136.58M 4.01M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
J&J USD 7.97B 689M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Mesa Laboratories USD 21.92M 1.78M 2024-09
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Option Care Health USD 1.2B 23.4M 2025-12
Stryker USD 2.69B 373M 2025-12
Surmodics USD 33.03M 24.58M 2024-09
Trinity Biotech USD 7.84M 3.14M 2025-09